A novel oral dual amylin and calcitonin receptor agonist (KBP-042) exerts antiobesity and antidiabetic effects in rats

Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action

(2013) Jonathan E. Campbell et al.   Cell Metabolism

Pioglitazone Acutely Reduces Energy Metabolism and Insulin Secretion in Rats

(2013) J. Lamontagne et al.   DIABETES

Inhibition of Calcitonin Gene-related Peptide (CGRP) has the Potential to Extend First-phase Insulin Secretion

(2013) H. Tanaka et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

PPARγ signaling and metabolism: the good, the bad and the future

(2013) Maryam Ahmadian et al.   NATURE MEDICINE

Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice

(2012) Toru Kusakabe et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Oral salmon calcitonin attenuates hyperglycaemia and preserves pancreatic beta-cell area and function in Zucker diabetic fatty rats

(2012) M Feigh et al.   BRITISH JOURNAL OF PHARMACOLOGY

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study

(2012) John B Buse et al.   LANCET

[d-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice

(2012) Matthew C. Leinung et al.   REGULATORY PEPTIDES

Control of energy homeostasis by amylin

(2011) Thomas A. Lutz   CELLULAR AND MOLECULAR LIFE SCIENCES

Banting Lecture 2011: Hyperinsulinemia: Cause or Consequence?

(2011) B. E. Corkey   DIABETES

Primer on Pramlintide, an Amylin Analog

(2011) Andrea N. Traina et al.   DIABETES EDUCATOR

A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats

(2011) M. Feigh et al.   DIABETES OBESITY & METABOLISM

Glucoregulatory effects and prolonged duration of action of davalintide: a novel amylinomimetic peptide

(2011) C. M. Mack et al.   DIABETES OBESITY & METABOLISM

Novel GLP-1 receptor agonists for diabetes

(2011) Alan J Garber   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Oral Salmon Calcitonin Improves Fasting and Postprandial Glycemic Control in Lean Healthy Rats

(2011) M. Feigh et al.   HORMONE AND METABOLIC RESEARCH

The Role of Pramlintide for Weight Loss

(2010) Kaelen C Dunican et al.   ANNALS OF PHARMACOTHERAPY

Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials

(2010) M. A. Karsdal et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Surrogate measures of insulin resistance: of rats, mice, and men

(2009) Kieren Mather   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Pioglitazone Acutely Reduces Insulin Secretion and Causes Metabolic Deceleration of the Pancreatic β-Cell at Submaximal Glucose Concentrations

(2009) Julien Lamontagne et al.   ENDOCRINOLOGY

Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight

(2009) C M Mack et al.   INTERNATIONAL JOURNAL OF OBESITY

Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats

(2008) J. Cacho et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Type 2 diabetes: pathogenesis and treatment

(2008) Michael Stumvoll et al.   LANCET

Central and peripheral administration of amylin induces energy expenditure in anesthetized rats

(2008) Toshimasa Osaka et al.   PEPTIDES

Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice

(2007) Sihoon Lee et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM